Compare EVCM & MANE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVCM | MANE |
|---|---|---|
| Founded | 2006 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.8B |
| IPO Year | 2021 | N/A |
| Metric | EVCM | MANE |
|---|---|---|
| Price | $10.20 | $57.00 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 4 |
| Target Price | $10.57 | ★ $78.33 |
| AVG Volume (30 Days) | 130.8K | ★ 237.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 145.45 | N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $588,907,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.03 | N/A |
| P/E Ratio | $102.90 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.66 | $36.26 |
| 52 Week High | $14.41 | $58.60 |
| Indicator | EVCM | MANE |
|---|---|---|
| Relative Strength Index (RSI) | 41.24 | 78.88 |
| Support Level | $9.81 | $39.73 |
| Resistance Level | $10.44 | N/A |
| Average True Range (ATR) | 0.74 | 3.72 |
| MACD | -0.13 | 0.79 |
| Stochastic Oscillator | 36.01 | 93.43 |
EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is mostly generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts.
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.